Karyopharm Therapeutics (KPTI) Non Operating Interest Expenses (2019 - 2026)
Karyopharm Therapeutics' Non Operating Interest Expenses was $13.14 million in Q2 2026, up 17.1% from $11.23 million a year earlier.
Powered by 
Analysis
Karyopharm Therapeutics (KPTI) Non Operating Interest Expenses (2019 - 2026) Analysis & Trends
On a trailing twelve-month basis, Karyopharm Therapeutics' Non Operating Interest Expenses was $48 million through Jun 30, 2026, up 7.1% year-over-year; for FY2025, it came in at $45.85 million, up 22.5% from FY2024.
- Non Operating Interest Expenses shows a five-year compound annual growth rate of 11.1% (FY2020 to FY2025).
- In earlier years, Non Operating Interest Expenses was $37.42 million in FY2024 (+57.1%), $23.82 million in FY2023 (-4.7%), $25 million in FY2022 (-4.0%) and $26.05 million in FY2021 (-4.0%).
- The Q2 2026 figure marks the highest quarterly Non Operating Interest Expenses in data going back to Q1 2019.
- Compared with a year earlier, Non Operating Interest Expenses was higher in six of the last seven quarters, with growth averaging 43.8%.
- The best year-over-year quarter for Non Operating Interest Expenses over five years was Q3 2024 (growth of 87.5%); the worst was Q4 2022 (a decline of 25.9%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 281.00 Mn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | - |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | -462.00 Mn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | -435.00 Mn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 673.00 Mn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 247.00 Mn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | - |
| 10 | Karyopharm Therapeutics | 25.18 Mn | -201.25 Mn | 32.35 Mn | 13.14 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 13.14 Mn |
| Dec 31, 2025 | 12.62 Mn |
| Sep 30, 2025 | 11.01 Mn |
| Jun 30, 2025 | 11.23 Mn |
| Mar 31, 2025 | 10.99 Mn |
| Dec 31, 2024 | 11.20 Mn |
| Sep 30, 2024 | 11.39 Mn |
| Jun 30, 2024 | 8.95 Mn |
| Mar 31, 2024 | 5.88 Mn |
| Dec 31, 2023 | 6.21 Mn |
| Sep 30, 2023 | 6.07 Mn |
| Jun 30, 2023 | 5.78 Mn |
| Mar 31, 2023 | 5.76 Mn |
| Dec 31, 2022 | 5.89 Mn |
| Sep 30, 2022 | 6.11 Mn |
| Jun 30, 2022 | 6.31 Mn |
| Mar 31, 2022 | 6.68 Mn |
| Dec 31, 2021 | 7.94 Mn |
| Sep 30, 2021 | 8.01 Mn |
| Jun 30, 2021 | 5.00 Mn |
API Access
Karyopharm Therapeutics Non Operating Interest Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=KPTI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-interest-expenses", "ticker": "KPTI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=KPTI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();